A study evaluating plasma soluble PD-1/PD-L1 levels in 117 advanced rectal cancer patients treated with nCRT revealed that high sPD-L1 levels after chemoradiation were associated with worse disease-free survival (13). The gene discussed is CD274; the disease is rectal cancer.